AR080834A1 - Proceso para la preparacion de benzoxaboroles - Google Patents
Proceso para la preparacion de benzoxaborolesInfo
- Publication number
- AR080834A1 AR080834A1 ARP110101147A ARP110101147A AR080834A1 AR 080834 A1 AR080834 A1 AR 080834A1 AR P110101147 A ARP110101147 A AR P110101147A AR P110101147 A ARP110101147 A AR P110101147A AR 080834 A1 AR080834 A1 AR 080834A1
- Authority
- AR
- Argentina
- Prior art keywords
- formula
- compound
- pharmaceutically acceptable
- salt
- acceptable salt
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 12
- 150000003839 salts Chemical class 0.000 abstract 9
- 239000003153 chemical reaction reagent Substances 0.000 abstract 3
- 125000006239 protecting group Chemical group 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 238000010511 deprotection reaction Methods 0.000 abstract 2
- DLEDOFVPSDKWEF-UHFFFAOYSA-N lithium butane Chemical compound [Li+].CCC[CH2-] DLEDOFVPSDKWEF-UHFFFAOYSA-N 0.000 abstract 1
- MZRVEZGGRBJDDB-UHFFFAOYSA-N n-Butyllithium Substances [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B31/00—Reduction in general
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/04—Esters of boric acids
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente solicitud trata de un proceso que comprende poner en contacto un compuesto de la formula (1) o una sal farmacéuticamente aceptable del mismo; con un reactivo de desproteccion, para formar un compuesto de la formula (2) o una sal farmacéuticamente aceptable del mismo; en donde R es H u OR1; R1 y cada R1' son grupos protectores; R1ö es H u OH, y n es 0, 1, 2, 3, 4, o 5. Reivindicacion 17: Un proceso que comprende los pasos de: a) bromar un compuesto de la formula (3) para formar un compuesto de la formula (4) en donde R es H u OR1; R1 es un grupo protector; y n es 0, 1, 2, 3, 4 o 5; b) poner en contacto el compuesto de la formula (4) con HN(R1')2 para formar un compuesto de la formula (5) o una sal del mismo, en donde cada R1' es un grupo protector; c) reducir enantioselectivamente el compuesto de la formula (5), o una sal del mismo, para formar un compuesto de la formula (6) o una sal del mismo; d) poner en contacto el compuesto de la formula (6), o una sal del mismo, con un reactivo borilante caracterizado por la siguiente formula: R3-O-B(OR2)(OR2) en la presencia de n-BuLi, para formar un compuesto de la formula (1) o una sal farmacéuticamente aceptable del mismo, en donde cada R2 es independientemente alquilo de 1, 2, 3, 4, 5, 6 átomos de carbono, o junto con los átomos de oxígeno con los que están unidos, forman un anillo de 5 o 6 miembros; y R3 es alquilo de 1, 2, 3, 4, 5, 6 átomos de carbono; y e) poner en contacto el compuesto de la formula (1), o una sal farmacéuticamente aceptable del mismo, con un reactivo de desproteccion, para formar un compuesto de la formula (2), o una sal farmacéuticamente aceptable del mismo en donde R1ö es H u OH.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32164210P | 2010-04-07 | 2010-04-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR080834A1 true AR080834A1 (es) | 2012-05-09 |
Family
ID=44763260
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP110101147A AR080834A1 (es) | 2010-04-07 | 2011-04-06 | Proceso para la preparacion de benzoxaboroles |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US9243003B2 (es) |
| EP (1) | EP2555625B1 (es) |
| JP (1) | JP5603998B2 (es) |
| KR (1) | KR101508562B1 (es) |
| CN (1) | CN102821609B (es) |
| AR (1) | AR080834A1 (es) |
| AU (1) | AU2011237681B2 (es) |
| BR (1) | BR112012024682B1 (es) |
| CA (1) | CA2794684C (es) |
| EA (1) | EA021532B1 (es) |
| ES (1) | ES2710105T3 (es) |
| IL (1) | IL222103A (es) |
| MX (1) | MX352607B (es) |
| SG (1) | SG184268A1 (es) |
| TW (1) | TWI503324B (es) |
| WO (1) | WO2011127143A1 (es) |
| ZA (1) | ZA201207386B (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2006333527B2 (en) | 2005-12-30 | 2013-08-01 | Anacor Pharmaceuticals, Llc | Boron-containing small molecules |
| US9440994B2 (en) | 2009-08-14 | 2016-09-13 | Anacor Pharmaceuticals, Inc. | Boron containing small molecules as antiprotozoal agents |
| WO2011094450A1 (en) | 2010-01-27 | 2011-08-04 | Anacor Pharmaceuticals, Inc | Boron-containing small molecules |
| JP6031122B2 (ja) | 2011-12-22 | 2016-11-24 | ミクウルク ファーマシューティカルズ，インコーポレイテッド | 抗微生物療法のための三環式ホウ素化合物 |
| US9598443B2 (en) | 2013-02-01 | 2017-03-21 | Anacor Pharmaceuticals, Inc. | Boron containing small molecules as antiprotozoal agents |
| US9644053B2 (en) * | 2013-03-15 | 2017-05-09 | Univation Technologies, Llc | Tridentate nitrogen based ligands for olefin polymerisation catalysts |
| KR101636431B1 (ko) * | 2013-07-30 | 2016-07-05 | 동아에스티 주식회사 | 트리사이클릭 벤즈옥사보롤 화합물, 이의 제조방법 및 용도 |
| SG10201914073PA (en) | 2013-08-09 | 2020-03-30 | Glaxosmithkline Ip No 2 Ltd | Tricyclic benzoxaborole compounds and uses thereof |
| EA038093B1 (ru) * | 2013-12-20 | 2021-07-05 | Глаксосмитклайн Интеллекчуал Проперти (№2) Лимитед | Способ лечения заболевания, вызванного инфекцией комплекса mycobacterium tuberculosis, с использованием (s)-(3-хлор-7,8-дигидро-2h-1,6,9-триокса-9a-борабензо[cd]азулен-2-ил)метанамина или его фармацевтически приемлемой соли |
| MA41495A (fr) | 2015-02-12 | 2017-12-19 | Anacor Pharmaceuticals Inc | Composés benzoxaborole et leurs utilisations |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69730737D1 (de) * | 1996-12-02 | 2004-10-21 | Chisso Corp | Optisch aktive nitroalkohol-derivate, optisch aktive aminoalkohol-derivate und verfahren zu ihrer herstellung |
| EP1567464B1 (en) | 2002-12-02 | 2007-04-18 | Solvias AG | Catalytic hydrogeneration of carbon-heteroatom double bonds |
| EP1856113B1 (en) * | 2005-03-08 | 2016-01-06 | Agency for Science, Technology and Research | Chiral bisoxazoline catalysts |
| KR100848491B1 (ko) | 2007-01-16 | 2008-07-28 | 영진약품공업주식회사 | 베타아미노기를 갖는 2-싸이아졸리딘 유도체, 이의약학적으로 허용 가능한 염 및 이의 제조 방법 |
| JO3396B1 (ar) * | 2007-06-20 | 2019-10-20 | Anacor Pharmaceuticals Inc | جزيئات صغيرة تحتوي على البورون |
-
2011
- 2011-04-06 BR BR112012024682-8A patent/BR112012024682B1/pt active IP Right Grant
- 2011-04-06 SG SG2012071296A patent/SG184268A1/en unknown
- 2011-04-06 CA CA2794684A patent/CA2794684C/en active Active
- 2011-04-06 EA EA201290872A patent/EA021532B1/ru not_active IP Right Cessation
- 2011-04-06 KR KR1020127029254A patent/KR101508562B1/ko active IP Right Grant
- 2011-04-06 AU AU2011237681A patent/AU2011237681B2/en active Active
- 2011-04-06 WO PCT/US2011/031384 patent/WO2011127143A1/en active Application Filing
- 2011-04-06 AR ARP110101147A patent/AR080834A1/es active IP Right Grant
- 2011-04-06 MX MX2012011632A patent/MX352607B/es active IP Right Grant
- 2011-04-06 TW TW100111877A patent/TWI503324B/zh active
- 2011-04-06 EP EP11766638.8A patent/EP2555625B1/en active Active
- 2011-04-06 JP JP2013503880A patent/JP5603998B2/ja active Active
- 2011-04-06 CN CN201180018031.4A patent/CN102821609B/zh active Active
- 2011-04-06 ES ES11766638T patent/ES2710105T3/es active Active
- 2011-04-06 US US13/639,594 patent/US9243003B2/en active Active
-
2012
- 2012-09-24 IL IL222103A patent/IL222103A/en active IP Right Grant
- 2012-10-02 ZA ZA2012/07386A patent/ZA201207386B/en unknown
-
2015
- 2015-12-15 US US14/969,467 patent/US20160168168A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP2555625A4 (en) | 2014-10-15 |
| AU2011237681B2 (en) | 2015-01-22 |
| KR101508562B1 (ko) | 2015-04-07 |
| AU2011237681A1 (en) | 2012-11-29 |
| CA2794684C (en) | 2018-04-24 |
| US9243003B2 (en) | 2016-01-26 |
| BR112012024682A2 (pt) | 2020-07-28 |
| JP5603998B2 (ja) | 2014-10-08 |
| ES2710105T3 (es) | 2019-04-23 |
| EA021532B1 (ru) | 2015-07-30 |
| JP2013523826A (ja) | 2013-06-17 |
| TW201202257A (en) | 2012-01-16 |
| BR112012024682B1 (pt) | 2021-06-08 |
| WO2011127143A1 (en) | 2011-10-13 |
| CA2794684A1 (en) | 2011-10-13 |
| US20160168168A1 (en) | 2016-06-16 |
| KR20130006506A (ko) | 2013-01-16 |
| EP2555625A1 (en) | 2013-02-13 |
| MX2012011632A (es) | 2013-02-27 |
| IL222103A (en) | 2016-12-29 |
| SG184268A1 (en) | 2012-10-30 |
| CN102821609B (zh) | 2015-03-25 |
| MX352607B (es) | 2017-11-30 |
| TWI503324B (zh) | 2015-10-11 |
| ZA201207386B (en) | 2014-03-26 |
| US20130035501A1 (en) | 2013-02-07 |
| EA201290872A1 (ru) | 2013-04-30 |
| CN102821609A (zh) | 2012-12-12 |
| EP2555625B1 (en) | 2018-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR080834A1 (es) | Proceso para la preparacion de benzoxaboroles | |
| AR085155A1 (es) | Procesos para preparar compuestos de quinolina y composiciones farmaceuticas que contienen dichos compuestos | |
| ECSP12012293A (es) | Ciertas amino-pirimidinas, composicioines de las mismas y métodos para el uso de los mismos | |
| ECSP15029636A (es) | Nuevos compuestos bicíclicos y su uso como agentes antibacterianos e inhibidores de beta-lactamasa | |
| AR095823A1 (es) | Compuesto de ciclopropanamina y uso del mismo | |
| AR083870A1 (es) | Inhibidores de la replicacion del vih | |
| UY35641A (es) | PROCEDIMIENTO DE SÍNTESIS PARA PREPARAR ANÁLOGOS MACROCÍCLICOS C1-CETO DE HALICONDRINA B, E INTERMEDIARIOS ÚTILES INCLUYENDO INTERMEDIARIOS CONTENIENDO GRUPOS ?SO2-(p-TOLILO) | |
| AR102468A1 (es) | Métodos para la preparación de ribósidos | |
| IN2014MN02106A (es) | ||
| ECSP12012292A (es) | Ciertas amino-piridazinas, composicioines de las mismas y métodos de uso de los mismos | |
| AR080819A1 (es) | Sintesis estereoselectiva de activos que contienen fosforo | |
| AR076027A1 (es) | Metodos e intermediarios para la preparacion de agentes farmaceuticos | |
| CR20140301A (es) | Derivados de betulina | |
| BR122020014853B8 (pt) | Éter, e, método de produção de um éter | |
| CO6260141A2 (es) | Inhibidores del co-transportador 2 sodio glucosa y metodos para la preparacion de los mismos y sus intermediarios | |
| BR112016010080A8 (pt) | compostos de pirazolopirimidina, composição farmacêutica e seu uso | |
| BR112015001839A2 (pt) | ibrutinibe deuterado | |
| NI201400022A (es) | Composición farmacéutica que comprende un ciclopolisacárido | |
| BR112012024403A2 (pt) | processo de preparo de derivados de amino-benzofurano | |
| BR112013001335A2 (pt) | processo de preparo de derivados de amino-benzoil-benzofurano | |
| BR112013021941A2 (pt) | agente terapêutico para tumor | |
| IN2014MN01521A (es) | ||
| BR112018069712A2 (pt) | composto ou um sal farmacologicamente aceitável do mesmo, composição farmacêutica, método para administração de uma quantidade eficaz de uma composição farmacêutica, e, inibidor de tnf-a. | |
| GEP20125548B (en) | New dihidroindolone compounds, a process for its preparation and pharmaceutical compositions containing them | |
| AR081893A1 (es) | Derivados de acido 1-(2-fluorobifenil-4-il)-alquil carboxilico para la terapia de la amiloidosis transtiretina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |